Introduction
Systems infl uencing the physiological response to normal exercise An individual' s capacity to perform aerobic exercise is dependent upon pulmonary, cardiovascular and skeletal muscle function. While proper physiological functioning of these three systems is important, cardiac output (Q), i.e. the product of heart rate and stroke volume, is the primary determinant of peak or maximal oxygen consumption (VO 2 ). Cardiac output is approximately fi ve liters/minute at rest and increases to approximately 20-25 and 30-35 liters/minute at maximal exercise in apparently healthy sedentary subjects and elite athletes, respectively. Th e ability of skeletal muscle to increase oxygen extraction during aerobic exercise plays a lesser but still important role in determining aerobic capacity. In apparently healthy subjects, the diff erence in oxygen (O 2 ) concentration between arterial and venous blood (a-vO 2 diff ) increases from approximately 5 mlO 2 /100 ml at rest to 16 mlO 2 /100 ml at maximal exercise. Th e Fick equation, defi ned as the product of Q and a-vO 2 diff , is used to describe VO 2 . While pulmonary function is not included in the Fick equation, the ability to increase gas exchange (oxygen intake and carbon dioxide removal) is of paramount importance to aerobic exercise capacity. Minute ventilation (VE), the product of respiratory rate and tidal volume, normally increases 10-20 fold at maximal aerobic exercise compared with resting values. It should be noted that pulmonary function is not typically the primary limiter of aerobic capacity, either in apparently healthy individuals or among patients diagnosed with cardiovascular disease. Even when the pulmonary, cardiovascular and skeletal muscle systems are all functioning properly, maximal aerobic capacity remains a rather heterogeneous phenomenon, since it is also infl uenced by age, sex, genetic predisposition and exercise habits. Considering these factors, the approximate range for maximal VO 2 in the apparently healthy population is between 20-55 mlO 2 ·kg -1 ·min -1 (1) .
Pathophysiological abnormalities associated with diminished aerobic capacity in patients with heart failure Severely compromised cardiac function is a primary pathophysiological component in heart failure (HF), and previous investigations have demonstrated a signifi cant relationship between cardiac output during exercise and peak VO 2 in this population [2] [3] [4] [5] . It has furthermore been well established that patients with HF frequently present reduced capillary density 6 and intrinsic skeletal muscle abnormalities, primarily in the form of diminished aerobic (mitochondrial) function [6] [7] [8] [9] [10] [11] [12] [13] . Given that aerobic capacity is reliant primarily on Q and secondarily on the a-vO 2 diff , as defi ned by the Fick equation, the signifi cant reduction in peak VO 2 frequently observed in patients with HF should be of no surprise. On average, peak VO 2 is approximately 50% lower in this patient population, compared with values observed in apparently healthy individuals matched according to age and sex. Moreover, peak VO 2 is approximately 25% lower in patients with HF, compared with patients diagnosed with coronary artery disease 14 . A relationship between pulmonary abnormalities and peak VO 2 has also been demonstrated in patients with HF [15] [16] [17] . Both resting 15 and maximal 16 measures of pulmonary function (i.e. inspiratory capacity), as well as diff usion capacity 17 , have all demonstrated signifi cant correlations with peak VO 2 . Th e degree to which these pulmonary abnormalities contribute towards the diminished aerobic capacity observed in HF, after accounting for the contributions of cardiovascular and skeletal muscle dysfunction, is unknown. Figure 1 illustrates the systems involved in the physiological response to aerobic exercise and how HF aff ects these systems.
The clinical applications of cardiopulmonary exercise testing in patients with heart failure Cardiopulmonary exercise testing (CPX) is a highly reliable 18 , well-accepted assessment technique in the HF population. American [19] [20] [21] and European [22] [23] [24] associations have endorsed its use. CPX is most often performed on a treadmill or lowerlimb ergometer using highly conservative ramping protocols, which are appropriate given the severely diminished exercise tolerance often observed in this population 25, 26 . Th e addition of ventilatory expired gas analysis to the standard exercise test enables measurement of VO 2 , carbon dioxide production (VCO 2 ) and minute ventilation (VE) over time. In addition to aerobic capacity, several other variables generated from CPX data have demonstrated clinical value with regard to exercise prescription, prognosis and response to a given intervention. Table 1 highlights key considerations for several CPX variables in patients with HF, which are described in greater detail in the following sections. It should be noted that the overwhelming majority of the literature cited in subsequent sections consists of studies performed on systolic HF cohorts. While the initial evidence indicates that CPX is also prognostic in patients with diastolic HF 27 , much more work is required in this area. Th erefore, with regard to the prognostic applications of CPX, the following information and recommendations primarily apply to patients diagnosed with systolic HF at this time. 
Peak oxygen consumption
Oxygen consumption at peak exercise remains the most frequently assessed variable obtained from CPX in the HF population and is often signifi cantly reduced, compared with normal predicted values for a given age. It is usually referred to as "peak VO 2 " in patients with HF, since a plateau in oxygen uptake is uncommon. Although ventilatory expired gas systems provide absolute peak VO 2 data (ml/min or l/min), it is most often reported clinically as a relative value (mlO 2 ·kg , decreased alveolar-capillary membrane conductance 28 , decreased heart rate variability 29 , increased pulmonary vascular pressures 30, 31 and increased brain natriuretic peptide [32] [33] [34] have all been signifi cantly correlated with lower peak VO 2 in patients with HF. Furthermore, several interventions have been shown to signifi cantly improve peak VO 2 , including aerobic exercise training 35 , inspiratory muscle training 36 , left ventricular assistance device implantation 37 , cardiac resynchronization therapy 38 , ACE inhibition 39 and sildenafi l 40 . Beta-blockade, however, has consistently been shown to have no eff ect on peak VO 2 41, 42 . Given the ability of peak VO 2 to refl ect varying degrees of disease severity, the consistently demonstrated prognostic value of this CPX variable should be of no surprise [43] [44] [45] . In fact, peak VO 2 remains the most frequently analyzed variable in clinical practice with regard to prognostic assessment. A peak VO 2 threshold of </≥ 14 mlO 2 ·kg -1 ·min -1 was established for prognostic purposes by Mancini et al. 43 in 1991 and is still used today. More recently, O'Neil et al. 46 found that this threshold might be too high in patients with HF who have been prescribed beta-blocking agents, a pharmacological class that improves survival but does not signifi cantly improve peak VO 2 . Given these fi ndings, a peak VO 2 threshold of </≥ 10 mlO 2 ·kg -1 ·min -1 may be more appropriate for present-day practice, particularly given the large percentage of patients with HF who are prescribed beta-blockers.
Although peak VO 2 is clearly an important prognostic variable, it does have limitations. Th e central limitation is dependence on maximal eff ort by the subject to attain a valid measurement. Mezzani et al. 47 demonstrated that the prognostic value of peak VO 2 ≤ 10 mlO 2 ·kg -1 ·min -1 was signifi cantly diminished in subjects who attained peak respiratory exchange ratio (RER) < 1.15 (clinical signifi cance of peak RER is discussed in the following section). For this reason, the prognostic veracity of peak VO 2 should be questioned among subjects who voluntarily terminate the exercise test and do demonstrate objective signs of maximal eff ort (i.e. high peak RER).
Peak respiratory exchange ratio
Achievement of at least 85% of age-predicted maximal heart rate is a classic indicator of maximal eff ort during the exercise test. Th e maximal heart rate response to exercise, however, has wide variability (± 12 beats per minute) in the general population and this has a negative impact on the ability to use heart rate to accurately gauge subject eff ort. Furthermore, the use of beta-blocking agents, now commonplace in the HF population, dramatically and heterogeneously blunts the heart rate response at maximal exercise, thus negating the validity of age-predicted maximal heart rate. Th e RER, defi ned as the ratio between VCO 2 and VO 2 , is the most accurate way to assess subject eff ort during CPX. As exercise progresses to higher intensities, lactic acid buff ering contributes towards VCO 2 , thereby increasing the numerator of this expression at a faster rate than the denominator. Th is physiological response to exercise is consistent across all individuals, making peak RER a reliable method for determining subject eff ort. Peak RER ≥ 1.10 is an indication of excellent subject eff ort during CPX. As a minimal threshold, peak RER < 1.00 during CPX that is terminated at the subject' s request, with the absence of electrocardiographic and/or hemodynamic abnormalities (ST segment changes, ventricular arrhythmias, drop in systolic blood pressure, etc.), may be indicative of poor subject eff ort. Caution should therefore be applied in using peak VO 2 for prognostic purposes when coinciding with a low peak RER. Assessment of peak RER is also important during interventional trials, to ensure comparable subject eff ort from one test to the next. A signifi cant increase in aerobic capacity following a given intervention, with similar peak RER values, strongly supports the assertion that observed improvements are secondary to physiological adaptation.
Oxygen consumption at ventilatory threshold
Minute ventilation, VO 2 and VCO 2 all increase in a similar linear fashion during the initial stages of progressive exercise tests, because of increased aerobic metabolism. At a given submaximal level of exercise unique to each individual, anaerobic metabolism begins to increase. From this point to maximal exercise, there are two signifi cant sources of CO 2 , consisting of byproducts from metabolism and lactic acid buff ering. Th is causes a nonlinear rise in VCO 2 in relation to VO 2 48 . Ventilation is driven by VCO 2 , thus causing a simultaneous nonlinear break in VE. Th e ability to detect this break point through ventilatory expired gas (ventilatory threshold) enables noninvasive estimation of the anaerobic threshold. Th e VO 2 , VCO 2 and VE responses to progressive CPX are illustrated in Figure 3 .
Th e v-slope, ventilatory equivalents and end-tidal O 2 /CO 2 methods have all been used to determine the ventilatory threshold. Techniques for these calculations are described elsewhere 49, 50 . Because of the signifi cantly reduced aerobic capacity and/or oscillations in exercise ventilation among patients with HF, accurate determination of the ventilatory threshold is not always possible. When detectable, VO 2 at ventilatory threshold, like peak VO 2 , is often signifi cantly reduced in patients with HF. Although there is some evidence to indicate that VO 2 at the ventilatory threshold is prognostically signifi cant 51 , its analysis is at present more important as a core component of exercise prescription, with regard to the overload principle (discussed in a subsequent section).
The minute ventilation -carbon dioxide production relationship
Minute ventilation and VCO 2 are tightly coupled during exercise, since the former is driven by the metabolic and anaerobic production of the latter. Th e VE-VCO 2 relationship is most often expressed as a slope value, calculated by linear regression Th e pathophysiological mechanism behind an abnormally elevated VE/VCO 2 slope in HF patients appears to be multifactorial. Centrally, an elevated VE/VCO 2 slope has been linked to ventilation-perfusion abnormalities (adequate ventilation and poor perfusion) 52, 53 . Additionally, elevated VE/VCO 2 slopes have demonstrated signifi cant correlations with abnormally increased chemo and ergoreceptor sensitivity [54] [55] [56] , both contributing towards exaggerated ventilatory response to exercise. Like peak VO 2 , the VE/VCO 2 slope has been signifi cantly correlated with decreased cardiac output 30, 31, 57 , increased pulmonary pressures 30 , decreased alveolar-capillary membrane conductance 58 and decreased heart rate variability 32, 33 . Also consistent with peak VO 2 , several interventions have been shown to signifi cantly improve the VE-VCO 2 relationship, including aerobic exercise training 35 , inspiratory muscle training 36 , left ventricular assistance device implantation 37 , cardiac resynchronization therapy 38 , ACE inhibition 39 and Sildenafi l 40 . In contrast to peak VO 2 , beta-blockade has also been shown to signifi cantly improve the VE-VCO 2 relationship 41, 42 . Given the link between the VE-VCO 2 relationship and pathophysiology, considerable attention has been given to the prognostic value of this CPX variable. Th e VE-VCO 2 relationship, again most often expressed as a slope, has consistently been shown to have high prognostic value in patients with HF 21, 45, [59] [60] [61] . For prognostic purposes, the most frequently used dichotomous VE/VCO 2 slope threshold is </≥ 34 49, 62 . A four-level ventilatory classifi cation (VC) scheme based upon the VE/VCO 2 slope (VC-I: < 29.9, VC-II: 30.0-35.9, VC-III: 36.0-4.9, VC-IV: ≥ 45.0) may, however, better identify varying levels of risk of adverse events 21 . Irrespective of the VE/VCO 2 slope threshold that is used, this variable should be calculated using all the exercise data (beginning of exercise to peak exertion), as opposed to submaximal calculations. Using all the exercise data to calculate the VE/VCO 2 slope has consistently been shown to provide stronger prognostic information 61, 63 . Furthermore, the VE-VCO 2 relationship appears to be prognostically superior to peak VO 2 62 . One of the primary reasons for the consistent prognostic superiority of the VE-VCO 2 relationship over peak VO 2 is its independence from subject eff ort. Furthermore, diagnostic studies have shown that, while both the VE-VCO 2 relationship and peak VO 2 are correlated with the same pathophysiological markers (reduced cardiac output, elevated neurohormonal markers, etc), the relationship with the former CPX variable and these pathophysiological markers is stronger 62 . Th e body of evidence in this area supports the use of the VE/VCO 2 slope as the primary variable assessed when CPX is performed for prognostic purposes in HF populations. It should be noted that, while the VE/VCO 2 slope has consistently been the strongest prognostic marker in previous investigations, peak VO 2 was retained in multivariate regression analyses in approximately half of the studies comparing these CPX variables 62 . For this reason, we recommend the analysis of both the VE/VCO 2 slope and peak VO 2 in clinical practice.
Exercise oscillatory ventilation
Minute ventilation generally increases linearly during progressive exercise tests. In HF populations, however, a number of patients present a waxing/waning VE pattern than has been defi ned as exercise oscillatory ventilation (EOV). Th e body of research investigating this phenomenon in patients with HF is not as robust as the work done in the areas of peak VO 2 and the VE-VCO 2 relationship. Th e analysis of EOV in HF does, however, rather convincingly indicate that disease severity is signifi cantly increased when this ventilatory abnormality is present 64, 65 . Although there is at present no universal defi nition of EOV, an oscillatory VE pattern at rest that persists for ≥ 60% of the exercise test at an amplitude ≥ 15% of the average resting value has been proposed 66, 67 . Figure 5 illustrates the VE pattern at rest and during a progressive exercise test in two patients diagnosed with HF: one with a normal pattern and the other with EOV.
Like elevated VE/VCO 2 slopes, EOV has been linked to increased chemosensitivity in patients with HF 68 . In addition, oscillations in cardiac function have been reported in patients with EOV 69 . Using quantitative algebraic analysis of dynamic cardiorespiratory physiology, Francis et al. 70 concluded that the primary pathophysiological factors resulting in EOV are circulatory delay and an increased chemorefl ex gain. While the impact of interventions on EOV are limited, both milrinone 64 and respiratory muscle training 36 have been shown to reduce the occurrence of EOV. Like peak VO 2 and the VE/VCO 2 slope, the presence of EOV appears to be a signifi cant predictor of adverse events 66, 67, 71, 72 . Furthermore, combined assessment of EOV and both peak VO 2 67 and the VE/VCO 2 slope 72 appears to enhance prognostic signifi cance, thus warranting their inclusion when using CPX data to assess prognosis. Th e combination of the independence of EOV from subject eff ort and its ability to refl ect cardiac pathophysiology may help to account for the strong prognostic value observed in previous investigations.
Other noteworthy cardiopulmonary exercise testing variables
Several other CPX variables have been assessed for their prognostic value in patients with HF. Th e oxygen uptake effi ciency slope (OUES), defi ned as the linear relationship between VO 2 and the logarithmic transformation of VE 73, 74 , the partial pressure of end-tidal carbon-dioxide production at rest 75 and during exercise 76 , and heart rate recovery (HRR) [77] [78] [79] have all demonstrated prognostic value among patients with HF. Furthermore, both the OUES 80 and HRR 81 have been shown to signifi cantly increase (improve) following an aerobic exercise training program among patients with HF. Th e additive prognostic value of these variables to peak VO 2 , the VE/VCO 2 slope and EOV is unclear at this time. Future investigations are needed in order to determine whether one or more of the variables mentioned should be added to multivariate modeling. Lastly, although not central to the prognostic assessment of patients with HF, monitoring of the hemodynamic and electrocardiographic response to CPX should be performed, particularly to identify potentially life-threatening situations that warrant test termination. A fall in systolic blood pressure during exercise compared with baseline measurements is a test termination criterion 20, 26 that potentially refl ects worsening left ventricular performance and may be a particularly ominous prognostic marker [82] [83] [84] [85] . Likewise, electrocardiographic evidence of ischemia and/or ventricular arrhythmia is a potentially serious indicator of worsening cardiac function during exercise and may also warrant termination of the CPX 26 .
Aerobic exercise training considerations in patients with heart failure
General principles of aerobic exercise training
Th e overload, specifi city and reversibility principles are key considerations in developing an eff ective aerobic exercise program. Th e overload principle relates to the fact that the training stimulus must be greater than what the physiological systems (i.e. cardiovascular and skeletal muscle) are accustomed to, for a positive adaptation to occur. Th e mode, intensity, duration and frequency of aerobic exercise are considered in combination, in order to safely use the overload principle for a given training program. Among patients with HF, overload can typically be achieved at a lower training level, particularly during the initial phases of the exercise program, compared with apparently healthy subjects. Th e specifi city principle states that physiological improvements are unique to the mode of exercise performed. For example, walking performance will be optimized with a training program primarily focusing on treadmill training as opposed to lower-limb ergometry or swimming. However, the positive health-related adaptations observed in patients with HF who participate in aerobic exercise training (discussed in a subsequent section) are achieved with any type of exercise using large muscle groups on a continuous basis (walking/running, lower-limb ergometry, elliptical devices, etc). For the overwhelming majority of patients with HF, the specifi city principle is less important than the fact that moderate aerobic activity of any type has numerous health benefi ts. Th e type of exercise should therefore be driven by individual preference and the availability of necessary equipment. Lastly, the reversibility principle states that positive training adaptations are not maintained if an individual returns to a sedentary behavior pattern. Life-long participation in the prescribed aerobic exercise program should therefore be a primary goal.
Specifi c recommendations for aerobic exercise prescription
Once contraindicated, aerobic exercise training is now a well-accepted lifestyle intervention for patients with compensated HF. Th e general frequency, duration and intensity recommendations for aerobic exercise in this population are 3-5 days/weeks, 30-60 minutes and 50-80% of maximal aerobic capacity, respectively 7, 14 . Walking (treadmill, track or other measured course), lower-limb cycle ergometry (mobile or stationary) or elliptical units enable physical stressing of larger muscle groups and are therefore acceptable types of exercise. Patients with HF should be guided to progress in frequency, duration and intensity towards the upper end of these aerobic exercise recommendations (i.e. 5 days per week, ~60 minutes per session, 70-80% of maximal aerobic capacity) over several weeks/ months. While all patients should strive to ultimately achieve these recommendations, it should be recognized that some level of physical activity is always preferable to a sedentary lifestyle.
While continuous aerobic exercise is the ultimate goal, some debilitated patients with HF will not be able to sustain an exercise session for the entire time period at a given intensity, particularly during the initial stages of the training program. In these instances, interval training, i.e. periods consisting of 1-2 minutes of exercise at the desired intensity followed by a lower intensity recovery period, should be used. Progression for patients performing interval training entails a gradual increase in the training duration at a given exercise intensity (1-2 to 2-4 to 4-6 minutes, etc.) before it becomes necessary to start the lower intensity recovery period. Th e goal is to guide these patients to progress to continuous bouts of aerobic activity (i.e. 30-60 minutes) over several weeks/months of training.
Titration of exercise intensity is the exercise prescription component most frequently used to optimize the overload principle. Irrespective of the method used to set exercise intensity, it should be established by an exercise test, preferably in conjunction with ventilatory expired gas analysis, performed at the start of the training program. Because peak VO 2 is signifi cantly improved as a result of certain pharmacologic interventions 39, 40 and cardiac resynchronization therapy 38 , the ideal is to perform the baseline exercise test after these treatment options have been implemented. Identifi cation of the ventilatory threshold via CPX is the preferred method for setting exercise intensity, since it enables identifi cation of a specifi c heart rate and workload at which anaerobic metabolism begins to increase during exercise. Setting the training intensity at the heart rate or workload corresponding to the ventilatory threshold ensures the overload principle is correctly used, since the typical patient with HF is not accustomed to exercising at levels that correspond to an initial increase in anaerobic metabolism. When the ventilatory threshold is undetectable, prescribing an exercise intensity of between 50% and 80% of peak VO 2 is appropriate. If the peak VO 2 range method is used to prescribe exercise intensity, it is recommended that HF patients begin the training program at the lower end of this range (50%) and gradually progress to ~80% of the baseline peak VO 2 over several weeks or months of aerobic exercise training. Th e heart rate associated with this peak VO 2 range can be used to monitor compliance with the prescribed exercise intensity during individual training sessions. Because of the potential day-to-day variability associated with heart failure medical management and/or stability, setting an individual exercise session at ± 5% of the specifi c target intensity is recommended 14 . For example, for a patient with a target exercise heart rate of 120 beats per minute, a ± 5% range would be 114-126 beats per minute. Alternatively, a perceived exertion level of 12-14 (on the Borg scale from 6 to 20) may be used to set the exercise intensity for patients who rate their exertion appropriately during the baseline exercise test.
Th e level of supervision, particularly at the initial stages of the exercise program, is an important consideration for this high-risk patient population. It is no longer considered necessary to recommend that all patients with HF undergo supervised exercise training with continuous electrocardiographic monitoring. Th is advanced level of supervision should, however, be strongly considered for patients with a history of cardiac arrhythmias, documented coronary artery disease that has not been surgically addressed or a low ejection fraction (≤ 25%), or whose characteristics resemble those of patients who suff ered sudden cardiac death 14 . Furthermore, irrespective of past medical history, patients who demonstrate an abnormal hemodynamic (hypertensive/hypotensive) response and/or electrocardiographic (ischemia/ventricular arrhythmias) abnormalities during the baseline exercise test should undergo supervised exercise training for some period of time. Th e duration and number of supervised exercise sessions is at the discretion of the health professional responsible for the training program. As a general guideline, patients should demonstrate an ability to appropriately self-monitor the exercise session and not have any abnormal physiological responses for several weeks before progressing to unmonitored exercise.
Documented benefi ts of aerobic exercise training
Th ere is now a rather impressive body of research demonstrating numerous health-related benefi ts associated with aerobic exercise training among patients with HF 7, 35, 62, 81, 86, 87 . Th e benefi ts that have been documented are listed in Table  2 . Furthermore, the adverse event rate with exercise training appears to be low 7 .
While one large trial examining the impact of aerobic exercise training on survival and hospitalization among patients with HF is ongoing 88 , no fi ndings have been published to date. A meta-analysis on this topic, pooling together a number of smaller exercise trials (combined n= 801), demonstrated a signifi cant increase in survival and signifi cant reduction in hospitalization in the exercise training group, compared with controls. Th ese results need to be confi rmed by future prospective investigations. Lastly, the work cited in this section was exclusively performed on patients diagnosed with systolic HF. Th e initial evidence indicates that the improvements in peak VO 2 and quality of life following exercise training are similar in patients with systolic and diastolic HF 89 . Despite these initial fi ndings, caution should be applied in extrapolating the documented benefi ts of exercising training listed in Table 2 to the diastolic HF population.
Complementary interventions also shown to improve aerobic capacity Several other interventions within allied health professionals' scope of practice have been shown to improve peak VO 2 and should be considered as potential complements to the aerobic exercise training program on an individual basis. Unlike in apparently healthy populations, resistance training programs have been shown to signifi cantly improve peak VO 2 among patients with HF 90 . In addition, resistance training improves bone mineral density, muscle mass and muscle force production to a greater extent than aerobic exercise programs do. In general, resistance training programs for patients with HF should focus on higher numbers of repetitions (≈1-3 sets of 10-12 repetitions) at a lower load (≈50% of one-repetition maximum). Additional general recommendations include a training frequency of 1-3 days per week, targeting large muscle groups with 4-9 training stations. Cable or hydraulic resistance systems may be preferable to free weights, from a patient-safety perspective. Subjects with a greater level of HF severity (New York Heart Class I-II vs. Class II-III) should be set tasks at the lower range of these recommendations 90 . As previously mentioned, subjects with HF may present varying levels of inspiratory capacity impairment that seems to be correlated with peak VO 2 15,16 . Inspiratory muscle training may improve respiratory muscle function and peak VO 2 36 . Th is treatment alternative should Table 2 . Benefi ts of aerobic exercise training in patients with heart failure. be considered when an HF patient presents an inspiratory capacity that is below the normative values predicted for the age and sex. Lastly, chronic electrical myostimulation has been shown to signifi cantly improve muscle force production 91 , VO 2 at ventilatory threshold 92 and peak VO 2 92,93 in patients with HF. Th ese programs typically consist of myostimulation to lower extremity muscle groups (bilateral quadriceps plus hamstring or calf muscles), for one to several hours most days of the week for several weeks. Implementation of a myostimulation program may be particularly advantageous for severely debilitated patients who initially are unable to perform continuous aerobic exercise sessions.
Summary
There is now a robust body of evidence demonstrating the clinical value of both CPX and aerobic exercise training for systolic HF populations. Cardiopulmonary exercise testing provides valuable prognostic information, is valuable in assessing the response to numerous interventions and is important in developing individualized exercise prescriptions. Participation in an aerobic exercise program is a safe means for improving functional capacity, quality of life and numerous physiological measurements. There is also promising evidence to indicate that aerobic exercise training improves morbidity and mortality in systolic HF populations. These findings need to be reproduced in patients with diastolic HF before concrete CPX and aerobic exercise training recommendations are made for this subgroup. Allied health professionals who are responsible for assessing and treating patients with HF should be aware of the importance of CPX, aerobic exercise training and complementary interventions and, when appropriate, advocate their implementation.
